Virtual Podium: The Present and Future of Biosimilars: Opportunity Abounds

So where are we now with biosimilars? Patent expirations and new bioanalytical advancements over the past couple of years have driven much debate about the development of biosimilars, and the potential threat that these present for current originator products. Dominique Gouty, Ph.D., of BioAgilytix, offers her expert opinion in this Virtual Podium presentation.

Dr. Dominique Gouty is the Vice President of Business Operations at BioAgilytix Labs, where she holds keys roles in both technical and commercial biopharmaceutical services. She has over 20 years of industry experience and a career spanning R&D, clinical operation, and manufacturing in multiple multi-national pharmaceutical organizations such as Eli Lilly and J&J, as well as smaller biotech companies, and CROs.

Share This